Related Experiment Video
Updated: May 13, 2025

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
Published on: September 13, 2022
Confronting Cholelithiasis: A Case Series of Patients With Sickle Cell Disease and Gallstones
Javed Jagroo1, Omar A Oudit1, Corey Knowles1
1Internal Medicine, Brookdale University Hospital Medical Center, Brooklyn, USA.
Insights
Sickle cell disease (SCD) patients have a high risk of developing gallstones due to increased hemolysis. Early screening and cholecystectomy are crucial for managing biliary complications and improving patient outcomes.
Area of Science:
- Hepatology
- Hematology
- Gastroenterology
Background:
- Sickle cell disease (SCD) is a genetic blood disorder characterized by abnormal hemoglobin, leading to chronic hemolysis and various complications.
- Hepatobiliary diseases, particularly gallstones (cholelithiasis) and bile duct stones (choledocholithiasis), are common but often underrecognized in SCD patients.
- Accelerated pigment gallstone formation in SCD is attributed to increased bilirubin levels resulting from chronic hemolysis.
Observation:
- This case series presents four adult SCD patients who developed symptomatic gallstones and required medical or surgical intervention.
- Presentations included choledocholithiasis with jaundice, hyperbilirubinemia with ductal dilation, acute cholecystitis, and gallstones in a patient with recurrent acute chest syndrome.
- One patient experienced postoperative acute chest syndrome, necessitating exchange transfusion, while others recovered post-surgery.
Findings:
- SCD patients exhibit a significant incidence of cholelithiasis, influenced by hemoglobin levels and elevated bilirubin.
- Symptomatic gallstones commonly manifest as right upper quadrant pain, potentially exacerbated by vaso-occlusive crises.
- Early detection and elective cholecystectomy can prevent serious complications such as choledocholithiasis and cholecystitis.
Implications:
- There is a need for heightened awareness and early screening for biliary disease in the SCD population.
- Elective cholecystectomy in at-risk SCD patients is recommended to prevent acute complications, reduce hospitalizations, and enhance quality of life.
- Further research and guideline development are essential for establishing standardized protocols for screening and managing gallstone-related hepatobiliary issues in SCD.
Abstract:
Sickle cell disease (SCD) is a prevalent hemoglobinopathy that leads to various complications, including hepatobiliary diseases, which are often underrecognized. Cholelithiasis and choledocholithiasis, resulting from accelerated pigment gallstone formation due to increased hemolysis, are common in SCD patients. This case series aims to raise awareness of the heightened risk of biliary disease in SCD and emphasize the need for early screening and management strategies. We present four cases of adult SCD patients who developed gallstones, each requiring medical intervention for biliary complications. The first case involved a 47-year-old woman with SCD and choledocholithiasis, presenting with right upper quadrant pain and jaundice. She underwent a laparoscopic cholecystectomy and endoscopic retrograde cholangiopancreatography (ERCP) for stone removal. The second case described a 25-year-old woman with a history of SCD, who had hyperbilirubinemia and dilated common hepatic duct. She successfully underwent ERCP and laparoscopic cholecystectomy after cholelithiasis was confirmed. The third case involved a 34-year-old man with acute abdominal pain and right-sided testicular pain, diagnosed with gallstones and early cholecystitis. Despite plans for surgery, he signed out against medical advice. The fourth case was a 28-year-old woman with recurrent acute chest syndrome, who presented with abdominal pain and was found to have multiple gallstones. She underwent laparoscopic cholecystectomy, but developed acute chest syndrome postoperatively, requiring exchange transfusion. All patients experienced post-surgical recovery, although one patient had complications related to acute chest syndrome. Hepatobiliary manifestations in SCD include cholelithiasis, choledocholithiasis, and other liver-related issues. The formation of pigmented gallstones is a direct result of chronic hemolysis, where increased bilirubin levels contribute to stone formation. The incidence of cholelithiasis in SCD patients is significant, with factors such as hemoglobin levels and bilirubin elevation increasing the likelihood of gallstone formation. Symptomatic gallstones often present with right upper quadrant pain, which can be exacerbated by vaso-occlusive crises. Early intervention, including elective cholecystectomy, can help prevent complications like choledocholithiasis, biliary colic, and cholecystitis. Despite a lack of formal guidelines for routine cholecystectomy in asymptomatic patients, evidence supports early surgical management to prevent further complications and reduce the need for emergent procedures. This case series highlights the importance of early screening and elective cholecystectomy for SCD patients at risk of biliary disease. Early intervention can prevent acute complications, reduce hospitalizations, and improve the quality of life for patients with SCD. Future research and guidelines should focus on establishing protocols for screening and management of gallstone-related hepatobiliary complications in this population.
More Related Videos
07:36Laparoscopic Common Bile Duct Exploration in Patients with a Previous History of Biliary Tract Surgery
Published on: February 10, 2023
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Related Concept Videos
Accessory Organs
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...